EUVIMEDEUVIMED entdecken
Open Access

Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways

Jia-Sin Yang, Chia-Hsuan Chou, Pei-Ni Chen, Yi-Hsien Hsieh, Chih-Hsin Tang, Shun-Fa Yang, Ko-Hsiu Lu

International Journal of Medical Sciences · 2026

DOI: 10.7150/ijms.128971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2026. Verfasst von Jia-Sin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, Phenanthridines, Bone Neoplasms, Amaryllidaceae Alkaloids. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma, the most prevalent bone cancer in teenagers, constitutes 3-5% of pediatric cancers and carries a poor prognosis due to its high metastatic potential. Although narciclasine induces apoptosis in various cancers, its effects on human osteosarcoma cells remain unclear. This study investigated the apoptotic impact of narciclasine on U2OS and HOS osteosarcoma cells. It was found that narciclasine induces dose-dependent apoptosis and sub-G1 phase cell cycle arrest. Human apoptosis array and Western blot analyses showed reduced inhibitors of apoptosis 1 (cIAP-1) and survivin expression while increasing cleaved caspases (8, 9, and 3) and PARP. Narciclasine activated extracellular signal-regulated protein kinases (ERK)1/2, c-Jun N-terminal kinases (JNK)1/2, and p38 phosphorylation. However, the JNK inhibitor (JNK-IN-8) suppressed the narciclasine-induced increase in cleaved caspase expression and apoptosis, whereas ERK and p38 inhibitors had no effect. These findings highlight the central role of JNK signaling in mediating extrinsic and intrinsic apoptotic pathways in osteosarcoma cells treated with narciclasine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaPhenanthridinesBone NeoplasmsAmaryllidaceae AlkaloidsHumansApoptosisCell Line, TumorMAP Kinase Signaling SystemGene Expression Regulation, NeoplasticSurvivinInhibitor of Apoptosis ProteinsJNK Mitogen-Activated Protein Kinases

Stichwörter der Autor:innen

JNK pathwayapoptosiscaspasenarciclasineosteosarcoma

Substanzen

PhenanthridinesnarciclasineAmaryllidaceae AlkaloidsSurvivinInhibitor of Apoptosis ProteinsJNK Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan.
  • Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan.
  • Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
  • Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan.

Zitieren

APA

Yang, J. S., Chou, C. H., Chen, P. N., Hsieh, Y. H., Tang, C. H., Yang, S. F., & Lu, K. H. (2026). Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.128971

Vancouver

Yang JS, Chou CH, Chen PN, Hsieh YH, Tang CH, Yang SF, et al. Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways. International Journal of Medical Sciences. 2026. doi:10.7150/ijms.128971

BibTeX
@article{Yang2026,
  author = {Yang, Jia-Sin and Chou, Chia-Hsuan and Chen, Pei-Ni and Hsieh, Yi-Hsien and Tang, Chih-Hsin and Yang, Shun-Fa and Lu, Ko-Hsiu},
  title = {Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways},
  journal = {International Journal of Medical Sciences},
  year = {2026},
  doi = {10.7150/ijms.128971}
}
Kostenlos starten →